Skip to main content

Peer Review reports

From: Serum levels of reactive oxygen metabolites at 12 weeks during tocilizumab therapy are predictive of 52 weeks-disease activity score-remission in patients with rheumatoid arthritis

Original Submission
13 Jun 2019 Submitted Original manuscript
26 Jun 2019 Author responded Author comments - Arata Nakajima
Resubmission - Version 2
26 Jun 2019 Submitted Manuscript version 2
21 Jul 2019 Reviewed Reviewer Report - David Liew
25 Jul 2019 Reviewed Reviewer Report - Jennifer Humphreys
31 Aug 2019 Author responded Author comments - Arata Nakajima
Resubmission - Version 3
31 Aug 2019 Submitted Manuscript version 3
21 Sep 2019 Author responded Author comments - Arata Nakajima
Resubmission - Version 4
21 Sep 2019 Submitted Manuscript version 4
Publishing
10 Oct 2019 Editorially accepted
16 Dec 2019 Article published 10.1186/s41927-019-0096-1

You can find further information about peer review here.

Back to article page